We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Making the Move to Continuous Bioprocessing
Making the Move to Continuous Bioprocessing
Blog

Bioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.

Read More

Developing RNA Medicines for Rare Genetic Diseases
Developing RNA Medicines for Rare Genetic Diseases
Blog

There are approximately 7,000 known rare diseases, however, less than 6% of these have a treatment. It is estimated that between 25–35 million Americans live with a rare disease. The company ProQR is dedicated to developing new therapeutics for patients living with untreated rare diseases. We caught up with Daniel de Boer, Chief Executive Officer at ProQR to learn more about the company’s approach to finding new treatments for rare genetic diseases.

Read More

Benefits of Using 3D Cell Models in Drug Discovery
Benefits of Using 3D Cell Models in Drug Discovery
Blog

As researchers explore therapeutic strategies for more complex and heterogeneous diseases the need for more physiologically relevant models has never been greater. Researchers are increasingly looking to 3D cell cultures, spheroids, organoids and microtissues to bridge the gap between 2D cell cultures and in vivo animal models.

Read More

Students Get Hands-on with Mass Spectrometry
Students Get Hands-on with Mass Spectrometry
Blog

We spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.

Read More

Surface Plasmon Resonance: Driving Better & Faster Decision-making in Drug Discovery
Surface Plasmon Resonance: Driving Better & Faster Decision-making in Drug Discovery
Blog

We recently spoke to Bruker’s JoAnne Bruno, Director Sales and Marketing and Sven Malik, Senior Application Specialist, to learn how surface plasmon resonance can be used to investigate the binding properties of small molecules, and how it can help researchers make better decisions about drug candidates and support efforts to design new molecules.

Read More

The Digital Solutions Offering Complete Control over Bioprocessing Workflows
The Digital Solutions Offering Complete Control over Bioprocessing Workflows
Blog

Robust data management is integral to both academic researchers and scientists in the pharmaceutical industry, especially for those working with bioprocessing workflows. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how the introduction of digital science solutions to the modern lab is transforming bioprocessing workflows by providing scientists with full control over procedures, data integrity and compliance

Read More

Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Blog

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines.

Read More

From Growing Cells to Growing a Business
From Growing Cells to Growing a Business
Blog

How do you start, grow and run a successful life science company? To find out we spoke to Dr Yichen Shi, CEO of Axol Bioscience.

Read More

Improving Preclinical Diabetes Research
Improving Preclinical Diabetes Research
Blog

Dr. Sven Schönecker from Multi Channel Systems discusses exciting technological developments in the preclinical drug development space for diabetes

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain
Say Hello to Regenerative Medicine and Goodbye to Back Pain
Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More